Atherosclerosis
Volume 209, Issue 1 , Pages 66-73 , March 2010

Ex vivo gene transferring of human dimethylarginine dimethylaminohydrolase-2 improved endothelial dysfunction in diabetic rat aortas and high glucose-treated endothelial cells

  • Chang-Wu Lu

      Affiliations

    • Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, 110# Xiang-ya Road, Changsha 410078, Hunan, PR China
    • ,
  • Zheng Guo

      Affiliations

    • Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, 110# Xiang-ya Road, Changsha 410078, Hunan, PR China
    • ,
  • Mei Feng

      Affiliations

    • Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, 110# Xiang-ya Road, Changsha 410078, Hunan, PR China
    • ,
  • Zhong-Zu Wu

      Affiliations

    • Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, 110# Xiang-ya Road, Changsha 410078, Hunan, PR China
    • ,
  • Zhi-Min He

      Affiliations

    • Cancer Research Institute, Central South University, Changsha 410078, Hunan, PR China
    • ,
  • Yan Xiong

      Affiliations

    • Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, 110# Xiang-ya Road, Changsha 410078, Hunan, PR China
    • Corresponding Author InformationCorresponding author. Tel.: +86 731 82355080; fax: +86 731 82355041.

Received 12 October 2008 ,Revised 3 August 2009 ,Accepted 17 August 2009.

References 

  1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053
  2. Farhangkhoee H, Khan ZA, Kaur H, et al. Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets. Pharmacol Ther. 2006;111:384–399
  3. Cooke JP, Tsao PS. Arginine: a new therapy for atherosclerosis?. Circulation. 1997;95:311–312
  4. Xiong Y, Lu R, Li YJ, Deng HW. Elevation of an endogenous inhibitor of nitric oxide synthase in diabetic rat serum. Zhongguo Yao Li Xue Bao. 1997;18:511–514
  5. Lin KY, Ito A, Asagami T, et al. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation. 2002;106:987–992
  6. Masuda H, Goto M, Tamaoki S, Azuma H. Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia. Br J Pharmacol. 1999;126:211–218
  7. Stuhlinger MC, Abbasi F, Chu JW, et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA. 2002;287:1420–1426
  8. Fard A, Tuck CH, Donis JA, et al. Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol. 2000;20:2039–2044
  9. Xiong Y, Fu YF, Fu SH, Zhou HH. Elevated levels of the serum endogenous inhibitor of nitric oxide synthase and metabolic control in rats with streptozotocin-induced diabetes. J Cardiovasc Pharmacol. 2003;42:191–196
  10. Xiong Y, Lei M, Fu S, Fu Y. Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes. Life Sci. 2005;77:149–159
  11. Boisvert FM, Cote J, Boulanger MC, Richard S. A proteomic analysis of arginine-methylated protein complexes. Mol Cell Proteomics. 2003;2:1319–1330
  12. MacAllister RJ, Parry H, Kimoto M, et al. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol. 1996;119:1533–1540
  13. Leiper JM, Santa Maria J, Chubb A, et al. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J. 1999;343(Pt 1):209–214
  14. Ito A, Tsao PS, Adimoolam S, et al. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation. 1999;99:3092–3095
  15. Stuhlinger MC, Tsao PS, Her JH, et al. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation. 2001;104:2569–2575
  16. Fu YF, Xiong Y, Guo Z. A reduction of endogenous asymmetric dimethylarginine contributes to the effect of captopril on endothelial dysfunction induced by homocysteine in rats. Eur J Pharmacol. 2005;508:167–175
  17. Yin QF, Fu SH, He P, Xiong Y. Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine. Atherosclerosis. 2007;190:53–61
  18. Xiong Y, Collins QF, An J, et al. p38 mitogen-activated protein kinase plays an inhibitory role in hepatic lipogenesis. J Biol Chem. 2007;282:4975–4982
  19. Lu CW, Xiong Y, He P. Dimethylarginine dimethylaminohydrolase-2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein. Nitric Oxide. 2007;16:94–103
  20. Monsalve E, Oviedo PJ, Garcia-Perez MA, et al. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells. Cardiovasc Res. 2007;73:66–72
  21. Dayal S, Rodionov RN, Arning E, et al. Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia. Am J Physiol Heart Circ Physiol. 2008;295:H816–H825
  22. Sorrenti V, Mazza F, Campisi A, et al. High glucose-mediated imbalance of nitric oxide synthase and dimethylarginine dimethylaminohydrolase expression in endothelial cells. Curr Neurovasc Res. 2006;3:49–54
  23. Chen Y, Park S, Li Y, et al. Alterations of gene expression in failing myocardium following left ventricular assist device support. Physiol Genomics. 2003;14:251–260
  24. Wakino S, Hayashi K, Tatematsu S, et al. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats. Hypertens Res. 2005;28:255–262
  25. Wang D, Gill PS, Chabrashvili T, et al. Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO. Circ Res. 2007;101:627–635
  26. Hasegawa K, Wakino S, Tatematsu S, et al. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2. Circ Res. 2007;101:e2–10
  27. Achan V, Tran CT, Arrigoni F, et al. all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase. Circ Res. 2002;90:764–769
  28. Pullamsetti S, Kiss L, Ghofrani HA, et al. Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension. FASEB J. 2005;19:1175–1177
  29. Noyman I, Marikovsky M, Sasson S, et al. Hyperglycemia reduces nitric oxide synthase and glycogen synthase activity in endothelial cells. Nitric Oxide. 2002;7:187–193

PII: S0021-9150(09)00698-4

doi: 10.1016/j.atherosclerosis.2009.08.035

Atherosclerosis
Volume 209, Issue 1 , Pages 66-73 , March 2010

Article Tools

* Image Usage & Resolution